Pricing Log in Create free account

Avalyn Pharma Inc. (AVLN) vs Verastem, Inc. (VSTM)

Avalyn Pharma Inc. and Verastem, Inc. are both Biotechnology companies. Avalyn Pharma Inc. and Verastem, Inc. are of similar size ($1.2B and $1.1B). Avalyn Pharma Inc. has the higher net margin (0.00% vs −178.4%) and the lower return on invested capital (−102.6% vs 0.00%). Across the 11 metrics below, Avalyn Pharma Inc. leads on 8 and Verastem, Inc. on 3.

Valuation

Metric AVLN VSTM Biotechnology median
P/E n/m n/m 10.60
P/S n/m 8.51 9.40
P/B 2.16 84.49 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 7.98 9.02
Earnings yield (357.99%) (21.95%) (32.88%)
Free cash flow yield (11.24%) (18.70%) (23.13%)

Profitability

Metric AVLN VSTM Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% (193.73%) 0.00%
Net margin 0.00% (178.38%) 0.00%
Free cash flow margin 0.00% (159.10%) 0.00%
Return on equity 0.00% 6,595.50% (51.96%)
Return on assets (43.95%) (88.02%) (46.06%)
Return on invested capital (102.61%) 0.00% 0.00%

Growth

Metric AVLN VSTM Biotechnology median
Revenue growth (TTM) — 286.13% 6.76%
EPS growth (last fiscal year) — 17.49% 29.88%
Revenue growth, 5-year CAGR — 12.11% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AVLN VSTM Biotechnology median
Debt to equity 0.04 11.82 0.00
Current ratio 33.12 1.93 4.97
Net debt to EBITDA — 0.76 1.01

Dividend

Metric AVLN VSTM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AVLN VSTM Biotechnology median
Market cap 1.18b 1.14b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack